Related Experiment Videos
[Tumor marker--present and future]
Rinsho Byori. the Japanese Journal of Clinical Pathology
|October 6, 1997
Summary
Cancer patient serum exhibits heat-stability due to tumor markers (TMs). These TMs, including glycoproteins and proteins, are classified into oncofetal, immature isozyme, and immature protein types, aiding cancer detection.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Context:
- Serum from cancer patients displays remarkable heat-stability.
- This heat-stability is attributed to the presence of specific tumor markers (TMs).
Purpose:
- To elucidate the nature and classification of heat-stable tumor markers in cancer patient serum.
- To understand the biochemical basis of serum heat-stability in oncology.
Summary:
- Tumor markers (TMs) like CEA, CA125, and CA19-9 contribute to serum heat-stability in cancer patients.
- TMs are categorized into three types: oncofetal proteins (e.g., AFP), immature isozymes (e.g., salivary amylase), and immature proteins in biosynthesis (e.g., PIVKA-II).
- The classification highlights the immature cellular characteristics of cancer cells.
Impact:
- Provides a framework for understanding tumor marker behavior and heat-stability.
- Enhances diagnostic potential by categorizing TMs based on their biochemical properties.
- Contributes to the molecular understanding of cancer biomarkers.